RefluxRaft Corp — SEC Form D Filing

RefluxRaft Corp filed an SEC Form D on April 22, 2026, reporting $345K raised in Health & Wellness.

Form D filing details

Filing
SEC Form D
Filing date
April 22, 2026
Amount reported
$345K
Industry
Health & Wellness
Website
https://refluxraft.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: VIRGINIA

Problem

Patients suffering from acid reflux, GERD, and LPR often experience discomforting symptoms like heartburn, sore throat, and hoarseness, and current treatments can have harsh side effects or long-term health impacts.

Solution

RefluxRaft offers a natural alginate-based therapy that forms a protective barrier above the stomach contents to manage acid reflux symptoms without entering the bloodstream, thereby avoiding common side effects associated with traditional medications.

Verdict

Investors expressed confidence in RefluxRaft Corp at this juncture due to its promising natural treatment approach for acid reflux, which they interpreted as a need for safer alternatives, not simply more of the same pharmaceutical options on the market. The implicit bet was on an increasing consumer demand for holistic health solutions, particularly as awareness of medication side effects grows. However, this bet carries limited upside given that the treatment's efficacy and market penetration have not yet been proven, raising concerns about long-term durability.

Source: SEC EDGAR Form D filing